期刊文献+

喹诺酮类抗菌药物的不良反应与临床合理应用

Adverse Reactions of Quinolones and Suggestions For Clinical Rational Use
下载PDF
导出
摘要 目的探讨喹诺酮类抗菌药物的各种不良反应与临床合理应用建议。方法选取2017年2月至2018年3月本院收治的采用喹诺酮类抗菌药物进行治疗的200例患者作为研究对象,随机分为实验组和常规组,各100例。随机分组后常规组不采取任何干预措施,实验组落实临床建议,探讨不良反应发生率。结果实验组不良反应发生率(7.00%)明显优于常规组(20.00%),统计学结果有意义(P <0.05)。结论严格掌握禁忌症与适应症,按照抗菌谱与肝肾功能等明确疗程,可降低喹诺酮类抗菌药物的不良反应发生率与毒性,提高临床疗效。 Objective To explore the adverse reactions and clinical suggestions for the rational use of quinolones.Methods From February 2017 to March 2018,200 patients treated with quinolone antibacterial agents in our hospital were selected as study subjects,and randomly divided into experimental group and conventional group,100 cases each. The routine group did not take any intervention after random group. The experimental group carried out clinical recommendations and explored the incidence of adverse reactions. Results The incidence of adverse reactions(7.00%)in the experimental group was significantly better than that in the conventional group(20.00%),and the statistical results were significant(P<0.05). Conclusion Strict control of contraindications and indications,specific dose and treatment in accordance with antimicrobial spectrum and liver and kidney function,reduce the incidence of adverse reactions and toxicity,and improve the clinical efficacy.
作者 崔国华 CUI Guohua(Guan County Central Hospital,Liaocheng,Shandong 252500,China)
机构地区 冠县中心医院
出处 《大医生》 2018年第11期101-102,共2页 Doctor
关键词 喹诺酮类抗菌药物 不良反应 临床建议 quinolones antibiotics adverse reactions clinical recommendations
  • 相关文献

参考文献6

二级参考文献38

  • 1李大魁,金有豫,汤光.马丁代尔药物大典[M].37版.北京:化学工业出版,2013:1487-1488.
  • 2Singh YN, Marshall IG, Harvey AL. Prejuncfional and postjunetional blocking effects of aminoglycoside, polymyxin, tetracycline and lineosamide antibiotics[J]. Brit J Anaesth, 1982,54(12) .- 1295-1306.
  • 3Wright JM, Collier B. Characterization of the neuromuscular block produced by clindamycin and lincomycin[J]. Can J Physi- ol Pharm,1976,54(6) : 937-944.
  • 4Lee JH, Soo-IL L, Chung CJ, et al. The synergistic effect oit gentamicin and clindamycin on neuromus- cular blockade[J]. Korean J Anesthesiol, 2013, 64 (2) : 143- 151.
  • 5卫生部.卫生部办公厅关于抗菌药物临床应用管理有关问题的通知[S].卫办医政发(2009)38号文.2009.
  • 6Moise PA,Birmingham MC, Sehentag JJ. Pharmaeokineties and metabolism of moxifloxacin [J]. Drugs Today (Barcelona, Spain~ 1998),2000,36(4) : 229-244.
  • 7国家药典委员会.中华人民共和国药典临床用药须知2010年版[M].北京:中国医药科技出版社,2011:765.
  • 8朱新波,胡国新,林丹.丁胺卡那和洁霉素联用对大鼠诱发肌缩、呼吸和血压的影响[J].温州医学院学报,1998,28(4):295-296. 被引量:8
  • 9朱新波.丁胺卡那霉素和洁霉素联用毒性观察[J].温州医学院学报,1999,29(3):219-220. 被引量:8
  • 10戴丽.喹诺酮类药物临床应用及不良反应[J].中华医院感染学杂志,2012,22(1):163-164. 被引量:28

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部